Tuberoinfundibular peptide of 39 residues (TIP39): molecular structure and activity for parathyroid hormone 2 receptor

2003 ◽  
Vol 44 (1) ◽  
pp. 141-153 ◽  
Author(s):  
K. Della Penna ◽  
F. Kinose ◽  
H. Sun ◽  
K.S. Koblan ◽  
H. Wang
1963 ◽  
Vol 26 (3) ◽  
pp. 317-329 ◽  
Author(s):  
C. F. MORGAN

SUMMARY This study showed that the application of hormones directly on the surface of the skin will result in uterine and vaginal weight stimulation, at times equal to and sometimes more effective than effects obtained by s.c. injection of the same hormones in the same concentration and over the same length of time. This effect was apparent, using sixteen different oestrogens. It was also shown that the uterine weight response is more sensitive and discriminatory in detecting differences between the potencies of oestrogens than is the vaginal weight response. The rank orders by both response variables, whether by topical or s.c. administration, were similar. It was shown statistically that the differences in potency of the sixteen oestrogens tested in this study are related more to certain molecular structure than to difference in solubility, molecular weight, or melting point. It was postulated that the potency of the oestrogens was related to their molecular structure and activity within the target organs.


1993 ◽  
Vol 23 (4) ◽  
pp. 339-344 ◽  
Author(s):  
C. Sadasivan ◽  
Vasantha Pattabhi ◽  
N. Gautham ◽  
Saradha Vasanth

2019 ◽  
Vol 74 (2) ◽  
pp. 136-144 ◽  
Author(s):  
Natalia G. Mokrysheva ◽  
Julia A. Krupinova ◽  
Elena V. Kovaleva

Wide prevalence of the parathyroid glands pathology and the need for new methods of diagnosis and treatment are forcing researchers all over the world to go more deeply into the pathophysiological mechanisms. A parathyroid hormone (PTH) is main cause of mineral disorders. In addition, humans have a family with similar in structure molecules that contribute to the maintenance of calcium and phosphate homeostasis. The family includes PTH, parathyroid hormone-related protein (PTHrP) and tuberoinfundibular peptide 39 (TIP39, also known as PTH2). The genes encoding these peptides have highly homologous amino acid regions in the N-(amino) terminal receptor-binding sites of each family member, as well as the preserved structure of their organization, which seems to be due to the presence of one parent gene. The variety of classical and “non-classical” effects allows to expand the understanding of these substances and consider them as hormones that go beyond the regulation of phosphorus-calcium metabolism. The review provides information on the structure and biosynthesis of these peptides, as well as a wide range of their effects on the human body.


2021 ◽  
Author(s):  
Xi Wang ◽  
Xi Cheng ◽  
Lihua Zhao ◽  
Yuzhe Wang ◽  
Chenyu Ye ◽  
...  

The parathyroid hormone receptor 2 (PTH2R) is a class B1 G protein-coupled receptor (GPCR) involved in regulation of calcium transport, nociception mediation, and wound healing. Naturally occurring mutations in PTH2R were reported to cause hereditary diseases, including syndromic short stature. Here we report the cryo-electron microscopy structure of PTH2R bound to its endogenous ligand, tuberoinfundibular peptide (TIP39), and a heterotrimeric Gs protein at a global resolution of 2.8 Å. The structure reveals that TIP39 adopts a unique loop conformation at N terminus and deeply inserts into the orthosteric ligand-binding pocket in the transmembrane (TM) domain. Molecular dynamics (MD) simulation and site-directed mutagenesis studies uncover the basis of ligand specificity relative to three PTH2R agonists, TIP39, PTH, and PTH-related peptide (PTHrP). We also compare the action of TIP39 with an antagonist lacking six residues from the peptide N terminus, TIP(7-39), which underscores the indispensable role of the N terminus of TIP39 in PTH2R activation. Additionally, we unveil that a disease-associated mutation G258D significantly diminished cAMP accumulation induced by TIP39. Together, these results not only provide structural insights into ligand specificity and receptor activation of class B1 GPCRs, but also offer a foundation to systematically rationalize the available pharmacological data to develop novel therapies for various disorders associated with PTH2R.


Sign in / Sign up

Export Citation Format

Share Document